As of 05 Nov 2026 10:52 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2022/080 (30 Sep 2022): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Ozempic® 1mg solution for injectionaffected product · inferred from phrasing | Out of stock, as stated | — not stated for this line | notice of 30 Sep 2022 |
| Ozempic® 0.5mg solution for injectionnamed by the source as remaining available · inferred from phrasing | Stated as available; can support only a partial uplift | — not stated for this line | notice of 30 Sep 2022 |
| Alternative oral and parenteral GLP-1 receptor agonists (RAs)class-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 30 Sep 2022 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Ozempic® 0.5mg solution for injection — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Semaglutide
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 30 Sep 2022. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 30 Sep 2022 | Medicine Supply Notification: Semaglutide (Ozempic® ) 1mg/0.74ml solution for injection 3ml pre-filled disposable device - Updated | Supply notification | Tier 2 | MSN/2022/080 |
Also recorded under
Bracketed names seen in this medicine's notice titles: ozempic. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2024)9 Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre- · issued 19 Mar 2024 · valid until end of 2024, as stated · matched by name PDF ↗